Teva multiple sclerosis drug Copaxone gets boxed warning on anaphylaxis risk
by
Contributor since / Followers
Contributor since / Followers
12 hours ago
JHVEPhoto
- The U.S. FDA has added a boxed warning to the labeling of Teva Pharmaceutical Industries’ (NYSE:TEVA) multiple sclerosis drug Copaxone (glatiramer acetate) citing the risk of a severe allergic reaction.
- The agency noted that although rare, anaphylaxis can occur at any